Peter V. Grauman
Impact in
- Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Acute Myeloid Leukemia Research 5
- Genetics 2
- BRCA gene mutations in cancer 1
- Genomics and Rare Diseases 1
- Co-authors
- Benjamin L. Ebert (9 shared papers)Brenton G. Mar (6 shared papers)Marie Ellen McConkey (4 shared papers)Donna S Neuberg (4 shared papers)Steven A. Carr (3 shared papers)Xiaoyu Li (1 shared paper)Stuart L. Schreiber (2 shared papers)Eamon Comer (3 shared papers)
- Journals
- Blood (7 papers)New England Journal of Medicine (2 papers)Clinical Chemistry (1 paper)Nature Communications (1 paper)Science (1 paper)
- Partner nations
- United StatesGermanySweden
In The Last Decade
Peter V. Grauman
15 papers receiving 7.0k citations
Peter V. Grauman's Hit Papers
Peers
Comparison fields: 5 of 72
- Hematology 3.3k
- Genetics 328
- Cancer Research 278
- Aging 29
- Molecular Biology 961
Countries citing papers authored by Peter V. Grauman
This map shows the geographic impact of Peter V. Grauman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter V. Grauman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter V. Grauman more than expected).
Fields of papers citing papers by Peter V. Grauman
This network shows the impact of papers produced by Peter V. Grauman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter V. Grauman. The network helps show where Peter V. Grauman may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter V. Grauman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes Hit paper breakdown → | 2014 | 3772 |
| 2 | Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells Hit paper breakdown → | 2013 | 1527 |
| 3 | Acute myeloid leukemia ontogeny is defined by distinct somatic mutations Hit paper breakdown → | 2014 | 818 |
| 4 | Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation Hit paper breakdown → | 2017 | 632 |
| 5 | 2014 | 161 | |
| 6 | 2017 | 107 | |
| 7 | 2018 | 57 | |
| 8 | 2019 | 28 | |
| 9 | 2018 | 19 | |
| 10 | 2017 | 17 | |
| 11 | 2012 | 3 | |
| 12 | 2013 | 2 | |
| 13 | 2016 | 2 | |
| 14 | 2014 | 1 | |
| 15 | 2015 | 1 |
About Peter V. Grauman
Peter V. Grauman is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Molecular Biology, having authored 15 papers that have together received 7.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Protein Degradation and Inhibitors (2 papers), Acute Lymphoblastic Leukemia research (2 papers), BRCA gene mutations in cancer (1 paper), Genomics and Rare Diseases (1 paper) and Genetic factors in colorectal cancer (1 paper). The work is most often cited by research in Hematology (3.3k citations), Genetics (328 citations), Cancer Research (278 citations), Aging (29 citations) and Molecular Biology (961 citations). Peter V. Grauman has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Benjamin L. Ebert, Brenton G. Mar, Marie Ellen McConkey, Donna S Neuberg, Steven A. Carr, Xiaoyu Li, Stuart L. Schreiber, Eamon Comer, Christie Ciarlo and Emily C. Hartman. Their work appears in journals such as Blood, New England Journal of Medicine, Clinical Chemistry, Nature Communications and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.